WINSTON-SALEM, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that senior members of the management team will be participating in the following two upcoming healthcare conferences in November: Guggenheim Healthcare Innovation Conference (Boston)Date: Wednesday, November 12, 2025Time: 10:00am ETFormat: Fireside ChatWebcast: Link Jefferies ...